• Foretinib Workflows for Cancer Drug Response

  2026-08-23

  Build more informative cancer assays with Foretinib by separating tumor cell growth inhibition from cell death and motility effects. This workflow combines dose–time optimization, orthogonal readouts, and translational model selection for reproducible multikinase research.

• BODIPY 581/591 C11 for Lipid Peroxidation

  2026-08-22

  Use BODIPY 581/591 C11 as a ratiometric fluorescent probe to quantify membrane oxidation in live cells, model membranes, and cardiovascular injury workflows. Its red-to-green shift supports antioxidant capacity evaluation while distinguishing lipid oxidation from broad, nonspecific ROS signals.

• Drug Response Metrics in Cancer Beyond Viability

  2026-08-21

  Hannah Schwartz’s dissertation shows why a single viability endpoint can obscure the distinction between proliferation arrest and true cell killing. Its central contribution is a comparative framework that separates relative viability from fractional viability and emphasizes their different magnitudes and time courses, improving interpretation of anticancer drug responses in vitro.

• EdU Cell Proliferation Kit for RA S-Phase Studies

  2026-08-20

  Turn DNA synthesis into a sensitive, non-radioactive TMB signal for direct S-phase analysis in rheumatoid arthritis fibroblast-like synoviocytes. This workflow connects ARL4C perturbation studies with practical cell proliferation measurement, genotoxicity testing, and pharmacodynamic drug evaluation.

• Perphenazine: From D2 Antagonism to Host Defense

  2026-08-20

  Perphenazine is more than a conventional neuropharmacology tool. Its dopamine D2 receptor antagonism, broader phenothiazine receptor-binding profile, mitochondria-mediated cell death induction, and emerging host-directed antibacterial activity create a translational framework for connecting neuronal signaling, cellular stress, and innate immunity. This article examines how researchers can use Perphenazine to build mechanism-focused workflows while maintaining appropriate boundaries between established evidence and exploratory application.

• Methicillin Sodium Salt: From Benchmark to Strategy

  2026-08-19

  Methicillin sodium salt remains more than a historical antibiotic: it is a mechanistic benchmark for MSSA biology, resistance-aware assay design, and translational decision-making. This article connects PBP-mediated cell-wall inhibition with modern antibacterial development, using the 2025 EAGLE-1 gepotidacin study to clarify what can—and cannot—be extrapolated across pathogens.

• Jasplakinolide Workflows for Actin Studies

  2026-08-19

  Jasplakinolide provides rapid, membrane-permeable control over actin assembly and filament stability for imaging, motility, viability, and antifungal workflows. This guide combines practical dose-finding, cation-aware assay design, and chemical-genetics logic to improve interpretation and reproducibility.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-18

  Song et al. show that murine norovirus uses caspase-3 activation and the membrane-rupture protein NINJ1 to release NS1 through an unconventional, cargo-selective pathway. The study connects viral immune modulation with regulated cell death and provides a framework for analyzing how intracellular proteins exit infected cells.

• Caffeine N2379 for Reliable Cell Assays

  2026-08-18

  Learn how Caffeine (SKU N2379) can support reproducible viability, proliferation, cytotoxicity, and metabolic workflows. This scenario-driven guide covers assay controls, stock preparation, dose interpretation, vendor selection, and responsible comparison with related translational research.

• Macrophage AREG Drives Fibrosis in Osteomyelitis

  2026-08-17

  The reference study identifies a macrophage–Adipoq+ precursor circuit that converts local inflammation into fibrotic vascular restriction around Staphylococcus aureus abscesses in bone marrow. Its findings connect amphiregulin-driven EGFR/mTOR/YAP signaling with impaired antibiotic delivery and suggest that antifibrotic targeting could complement antimicrobial therapy.

• Sulfo-NHS-Biotin Workflows for CADASIL Models

  2026-08-17

  Use Sulfo-NHS-Biotin to separate vascular surface remodeling from intracellular signaling in NOTCH3 R545C CADASIL models. This practical workflow combines cell surface protein labeling, streptavidin capture, and immunoprecipitation-compatible readouts while emphasizing membrane integrity, reaction control, and assay-specific optimization.

• TCAIM Control of OGDH and Mitochondrial Metabolism

  2026-08-16

  Wang and colleagues identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The study reveals a proteostasis-based mechanism for tuning OGDH complex activity, carbohydrate catabolism, and mitochondrial metabolism in cultured cells and mice.

• Methyl-β-cyclodextrin: Membrane Study Guide

  2026-08-15

  Methyl-β-cyclodextrin (SKU C6939) provides a soluble research reagent for membrane cholesterol extraction and controlled investigation of membrane organization. It is suitable for biochemical and cell-based research workflows, but product specifications do not establish a universal dose, exposure time, diagnostic use, or medical application.

• Sulfo-NHS-SS-Biotin for Reversible Labeling

  2026-08-15

  Sulfo-NHS-SS-Biotin combines aqueous, surface-selective amine labeling with a cleavable disulfide linker, making it useful for both protein purification and trafficking studies. Its reversible capture format helps distinguish cell-surface abundance from intracellular retention while preserving an option for reductive release.

• Mdivi-1: Reliable DRP1 Assay Workflows

  2026-08-14

  This scenario-driven guide explains how Mdivi-1 (SKU A4472) can improve the interpretation of cell viability, apoptosis, and mitochondrial dynamics experiments. It connects formulation, controls, orthogonal readouts, and cross-model evidence to practical laboratory decisions without overstating what a DRP1 perturbation proves.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page